Upload
icca
View
115
Download
1
Embed Size (px)
Citation preview
Healthcare Meetings Sector: Where does it Hurt this Year?
55th ICCA Congress
Why are we here?• Pain Points
• Regulations and codes
Why are we here?• Pain Points
• Regulations and codes
• Cures & Sticking Plasters• Reshaping of medical meetings• Take part in the evolution – short & long term
Why are we here?• Pain Points
• Regulations and codes
• Cures & Sticking Plasters• Reshaping of medical meetings• Take part in the evolution – short & long term
• Outcomes• You will have clarity and new ideas• Identify key ideas for distribution by ICCA
Who is in the Room?
Session FlowBrief presentations by 2 speakers (10 minutes each)
Hold questions until the end
Discussion at your table
(20 minutes)Identify new
ideas
What solutions can be
implemented in your organization
Record ideas/solutions on flip charts
Identify 1-2 key ideas from each
table
Repeat 2x – Total of 6 presentations and 3 table discussions
Closing discussion – identify key ideas, conclusions, recommendations
Areas of Discussion
• Compliance is here to stay – how to work within the restrictionsRound One
• How can venues and destinations strengthen their partnership with medical meetings
Round Two
• The changing role of medical associations and societies
Round Three
Christine SainvilEthical Med Tech
Compliance is here to stay – how to work within the restrictios
www.medtecheurope.org
MedTech EuropeCode of Ethical Business Practice
Christine Sainvil, Compliance Officer 55th ICCA Congress, KuchingNovember 15th, 2016
www.medtecheurope.org
What is MedTech Europe?
New MedTech Europe Code
What arethe main
changes?
New MedTech Europe Code
How could the
Code affect Healthcare
Events Organisers?
MedTech Europe
Initiative
Trusted Partner initiative
Structure of the presentation
www.medtecheurope.org 1
WHAT IS MEDTECH EUROPE?Part 1
www.medtecheurope.org
MedTech Europe is an Alliance of European medical technology industry associations
Mission to make value-based, innovative medical technology available to
more people, while supporting the transformation of healthcare systems
onto a sustainable path
Membership 112 Corporate Members;
49 National Associations and Associates National Associations
www.medtecheurope.org
HCPs are trained on how to use technologies
The industry liaises regularly with HCPs to ensure that the technologies are updated and maintained
HCPs actively participate in the research to develop new technologies
This close collaboration is key to develop innovative technologies to treat patients
MedTech industryHCPs
The MedTech industry and HCPs collaborate closely throughout several stages of the development and use of medical technologies.
MedTech’s major differences with Pharma
www.medtecheurope.org 1
WHAT ARE THE MAIN CHANGES?Part 2
www.medtecheurope.org
Six biggest changes
Phasing out direct sponsorship
Common chapter on general criteria
for events Transparency of
educational grants
New chapter on demonstration
products and samplesCommon independent
enforcement mechanismAgreed
definitions
www.medtecheurope.org
Companies select individual HCPs and financially support their participation to Third Party Organised Events.
Companies provide educational grants to hospitals, medical societies and other third parties to support genuine medical education.
“Direct sponsorship”
Such financial support typically covers some or all of the travel, lodging and registration costs of the HCP.
These include educational grants provided to support HCP participation to Third Party Organised Event. HCPs are selected by the receiver of the grant.
“Educational grants”
Two types of industry support to Third Party Organised Events
www.medtecheurope.org
Transposition of the new code
Phasing out direct sponsorship
+Collecting data for disclosure
Timelines
2016 2017 2018
Starting to disclose
Direct Sponsorship
banned
New Codecomes into
force
19
www.medtecheurope.org 1
CODE: IMPACT ON HEALTHCARE EVENTS ORGANISATIONS
Part 3
www.medtecheurope.org
Grants will be publicly disclosed, ensuring increased transparency of the funds allocated to medical education
Conferences will still need to comply with specific requirements and with the Conference Vetting System
Grants can only be provided to legal entities but never individuals and will require a written contract & other related documentation
Companies will be able to define the type of recipients which should be eligible for the grant but not individual recipients
Companies must have an internal & independent process based on objective criteria to assess the grant requests
How the rules for educational grants will change?
www.medtecheurope.org
Definition of Educational Grants?
• Provision of funding, products or other in kind support to an HCO by or on behalf of a
Company on a restricted basis for use solely for the support and the advancement of genuine
medical education of HCPs, patients and/or the public on clinical, scientific and/or healthcare
topics relevant to the therapeutic areas in which the Company is interested and/or involved (i.
e. sponsorships , Fellowships, Grants for public awareness campaigns)
Publication where?
Unique European website (N.B.: if national transparency rules in place, no double reporting).
By whom? Reporting by companies.
When? 2018 (of 2017 data)
1. Public disclosure of Educational Grants
17
www.medtecheurope.org
No/minor changes of the existing criteria – CVS* needs to approve congresses before any support provision
• Image & Reputation: How would that support be perceived by the public/authorities?
• Scientific programme directly related to the medical practice of HCPs
- No social, sporting and/or leisure activities or other forms of entertainment
• Location and venue should be in or near a city or town which is a recognised scientific or business centre
- No luxurious, tourist/holiday-oriented, entertainment location & venues
- No events during touristic season
- No locations that are hard to access or that are not centrally located
• Guest packages: No facilitation or payment for meals, travel, accommodation or other expenses for guests of HCPs
• Reasonable hospitality and travel tied in to the duration of the event
- No top category or luxury hotels for accommodation
- No luxurious dinners
- Only economy or standard class for travel by plane unless the flight time is longer than 5 hours
• Communication support.
* CVS = Conference Vetting System – more on www.EthicalMedTech.eu
2. Compliance with Events requirements, incl. CVS
17
www.medtecheurope.org
Events
Scientific Programme
Geographic Location and
Venue
GuestsPackages
Hospitality
Accommodation
CommunicationSupport
The Conference Vetting System remains
14
www.medtecheurope.org
• Grants can only be given to an HCO (never an HCP)
- The payment (or provision of other support) always be made out in the name of the
HCO
- Grants cannot be provided in response to requests made by HCPs unless the HCP
is an employee or officer of the qualifying organisation or entity and submits the
request in writing on behalf of the HCO.
• The grant request needs to be done in writing to the Company, and may include:
- information on the HCO (e.g. legal status)
- If previous grants: Information how previous funds have been used in accordance to
the terms and conditions of the previous Grant agreement.
• Written Grant agreement signed by both parties before provision of any funds.
• Records of everything should be kept.
3. Documentation principle
17
www.medtecheurope.org
Principle:
• Companies will be able to define in the Grant agreement with the HCO, the type of
“final” recipients/beneficiaries (e.g. Romanian ostomy nurses) which should be
eligible for the grant but not individual recipients/beneficiaries (e.g. Dr. X).
Practically:
• HCOs, in particular scientific societies, and PCOs will need to consider how to
proceed for this selection
• Some HCOs reported that they constituted a database are considering adding
objective criteria such as submission of an abstract.
4. Identification of the final recipients of the Grant
17
www.medtecheurope.org
Principle:
• Companies must have an internal & independent (i.e. not primarily sales-driven)
process based on objective criteria to assess the grant requests.
Practically:
• The HCO can make a written request, containing sufficient information to permit an
objective evaluation of the request to be carried out by the Company, to a
Company.
5. Independent process within the companies
17
www.medtecheurope.org 1
MEDTECH EUROPE “TRUSTED PARTNER” INITIATIVE
Part 4
www.medtecheurope.org
General concerns
- Medical education of HCPs at stake – vulnerable HCPs/countries
- Concern that industry funding to support education/events may decrease
Technical concerns
- Which HCPs to invite? Which database? What selection process? How to reach the HCPs?
- Travel & accommodation management – infrastructure/HR – associated costs
- Timing alignment (planning vs. funding)
Key concerns of Conference Organisers
17
www.medtecheurope.org
Trusted Partner Initiative
Expression of interest from conference organising company to
MedTech Europe
Online training on MedTech
Europe Code+
Online assessment
Charter signature
+
Accreditation of Trusted
Partner status
www.medtecheurope.org
Supporting tools
Leaflet for HCOs Leaflet for HCPs
These tools are available atwww.medtecheurope.org
And in the Member’s Area corner
www.medtecheurope.org
FOR MORE INFORMATION
Christine SainvilCompliance Officer
Pablo Rojas AbadLegal & Compliance Assistant
61
Clarisse AilletMedical Education consultant
Martin JensenIPCAA
Compliance is here to stay – how to work within the restrictios
ICCA World CongressKuching, November 15th 2016
Martin N JensenIPCAA Co-PresidentHead Global Congress & Event Management &
Interim Head of Global Customer Interaction Management H. Lundbeck
Disclousre
• No honorarium paid
• Flights & Accommodation covered by ICCA & IPCAA
Please note that the following slides ‘are the personal opinion of the speaker basing on his observation and experience as professional and IPCAA Co-President.
Mission
‘To ensure the most beneficial outcome for all parties involved in medical congresses, through the development of common and consistent congress policies and through recognised partnerships with medical societies.’
Pharmaceutical IndustryChanging Landscape
Public Perception and scrutiny has led to focus on Trust and Transparency
Significant Industry Engagement - US Sunshine Act
- EFPIA Data Transparency Initiative
- Specific Country Regulations e.g. Japan, Australia
Area of focus: Destination Location & Venue Structure Scientific Program Transfer of Value
New Standard Compliance Master 37
Medical Congresses
Scientific Program
Symposia Exhibition
Scientific Poster Other Scientific Engagements
Social Program Support via
Registration Fee
Excursions (Support)
Partner Program (support)
Gifts and Gadgets
New Standard Compliance Master 38
Medical Congresses
Scientific Program
Symposia Exhibition
Scientific Poster Other Scientific Engagements
No Social Program Support via
Registration Fee
No Excursions (Support)
No Partner Program (support)
Gifts and Gadgets
Provision
New Standard Compliance Master 39
EFPIA
European Federation of Pharmaceutical Industries and Associations
• Represents the pharmaceutical industry operating in Europe
- 33 National Associations- 40 leading companies- Including Vaccines Europe and- European Biopharmaceutical Enterprises
• Members are bound by a Code of Practice
• Maintains e4ethics assessment platform• Disclosure Code launched 2014
- Data collection 2015- Reporting in 2016- 33 different reporting requirements
New Standard Compliance Master 40
Leadershp Statement
New Standard Compliance Master 41
General statements of industry leaders CEOs of 23 global companies
• Full respect for the role that EU legislation plays in regulating interactions between pharmaceutical companies and healthcare professionals.
• Commitment to working towards greater transparency, accountability and ethical behavior within an industry framework of self-regulation.
• Adherence to EFPIA Codes establishing standards for appropriate behavior in companies relations with healthcare professionals and patient organizations is essential – breaches should not be tolerated.
Similarities
• HCP interaction• Applies to sponsoring delegates
• Although EFPIA relates to all of article 9 of it guidelines including sponsorship activities
• EU (33 membership states) only• Review of programs, venues,
destinations, hospitality & accompanying persons
Differences
• Spouse program• Recommendation vs must follow
review process:• EUCOMED done by conference
owners• e4Ethics done by EFPIA
• Direct Sponsorship– EFPIA Allows post 2018– EUCOMED / MedTech does not
EFPIA vs EUCOMED / MedTech
HCP’s Learning Journey & Impact of Disclousre
Key points from research survey of HCP vs reputation survey & focus group conducted by Lundbeck
General satisfaction with learning resources
The average response for the current options available to you in terms of clinical disease information online was 7.1%
39% of HCPs stated that they have not had a positive delegate experience at many of the meetings they have attended
Face-to-face engagement
What needs to improve? HCP networks for virtual attendees and pharma’s use of social media for those attending
Offline engagement with industry such as poster sessions, exhibiting booth and networking preferable to digital/social
Attending educational sessions, attending sponsored symposia and browsing poster sessions were the top three preferred methods of learning at the event
Education (47%), Face-to-face networking/meetings (24%) and Learning about new technologies (12%) were the top three reasons
Top two benefits to attending were both networking – one with experts in their field, the other with peers
Types of content offered and use of mobile technology
Learning experience preferences
Following virtually
Co-creation57% would consider authoring a medical article
The most preferred method for doing this was Downloadable materials (such as presentations/slides) from medical society websites, the second was live virtual broadcasts and thirdly accessing content from pharma websites
61% find it difficult to attend meetings and would like information to be available online and in real time, so that they can access it remotely, around their practice commitments.
85% of HCPs would like to have greater input into the agenda
Disclosure Impact
Societies and PCO’s needs to ready to be disclosed
Industry will support HCO’s rather than HCP’s -however not to work around disclosure code
Regional difference in collaboration between HCO’s & HCP
Societies must become more competitive in its offerings to attract the right delegates, as delegates will be more selective
Delegates will go for fewer congresses and either go for one large with many areas of interest or few small with specialist – but not both and not mid size
Self-employed HCP’s tend to stay shorter at congress than those employed by an HCO
Some HCP’s will not accept sponsorship – or at least for a whileEducation must continue
Industry is working in greater details with societies to attract a different type of delegate (the new customer) on demand when required, both online and on site - 24/7/365
Industry is working with societies to change the behavior of the delegates onsite (more scientific material vs promotional) i.e. moving from marketing driven approach to Scientific Education
Questions?
New Standard Compliance Master 51
AMEX:
https://www.amexglobalbusinesstravel.com/research-insights/
ASHFIELD:
https://www.ashfieldhealthcare.com/gb/post/the-changing-face-of-physician-needs/
Links to Surveys
New Standard Compliance Master 52
Co-Presidents:Martin N. JensenChristian-Claus Roth
Executive Officer:Rita Gutzwiller
IPCAA SecretariatPO Box 182CH-4013 BaselSwitzerland
Tel: +41 61 821 [email protected]
Thank you for your attention!
ICCA World CongressKuching, November 15th 2016
Table DiscussionHow does this impact
your world
What are your 2 main challenges with the
industry codes
What solutions can be implemented in your
organization
Record ideas/solutions on flip charts
Identify 1-2 key ideas from each table
And please share the talk time
Christoph TessmarBarcelona Convention
BureauHow can venues & destinations strengthen their
partnership with medical meetings
The Role of the Barcelona Convention Bureau
Related to Compliance
38% Medical & Pharma Industry
S B E R C J H Y U I M R A J H G V F R U Z
I K L J N T Y T R A I N I N G D C B A H D
O R G A N I Z A T I O N E X R G T I J N B
C V F R G H N J Z L E A D E R S H I P L K
O H K K N O W L E D G E S C X A W Q N U K
N H Y I K L P C D F F C A W E Q X Z L P H
Y J I U B F R E C O M M E N D A T I O N M
L B C R Y A F N U K P Q D C Z A R E C E J
V Y T J B B N H D S E W C G T H M D F F R
L J K I A A C W P I Y V N H D L C O E S A
Farmaindustria: The Spanish
Code of Practice
S B E R C J H Y U I M R A J H G V F R U Z
I K L J N T Y T R A I N I N G D C B A H D
O R G A N I Z A T I O N E X R G T I J N B
C V F R G H N J Z L E A D E R S H I P L K
O H K K N O W L E D G E S C X A W Q N U K
N H Y I K L P C D F F C A W E Q X Z L P H
Y J I U B F R E C O M M E N D A T I O N M
L B C R Y A F N U K P Q D C Z A R E C E J
V Y T J B B N H D S E W C G T H M D F F R
L J K I A A C W P I Y V N H D L C O E S A
Members of the Barcelona
Convention Bureau
S B E R C J H Y U I M R A J H G V F R U Z
I K L J N T Y T R A I N I N G D C B A H D
O R G A N I Z A T I O N E X R G T I J N B
C V F R G H N J Z L E A D E R S H I P L K
O H K K N O W L E D G E S C X A W Q N U K
N H Y I K L P C D F F C A W E Q X Z L P H
Y J I U B F R E C O M M E N D A T I O N M
L B C R Y A F N U K P Q D C Z A R E C E J
V Y T J B B N H D S E W C G T H M D F F R
L J K I A A C W P I Y V N H D L C O E S A
Rates alignment with the Codes
S B E R C J H Y U I M R A J H G V F R U Z
I K L J N T Y T R A I N I N G D C B A H D
O R G A N I Z A T I O N E X R G T I J N B
C V F R G H N J Z L E A D E R S H I P L K
O H K K N O W L E D G E S C X A W Q N U K
N H Y I K L P C D F F C A W E Q X Z L P H
Y J I U B F R E C O M M E N D A T I O N M
L B C R Y A F N U K P Q D C Z A R E C E J
V Y T J B B N H D S E W C G T H M D F F R
L J K I A A C W P I Y V N H D L C O E S A
Barcelona Convention Bureau
Course of Action
S B E R C J H Y U I M R A J H G V F R U Z
I K L J N T Y T R A I N I N G D C B A H D
O R G A N I Z A T I O N E X R G T I J N B
C V F R G H N J Z L E A D E R S H I P L K
O H K K N O W L E D G E S C X A W Q N U K
N H Y I K L P C D F F C A W E Q X Z L P H
Y J I U B F R E C O M M E N D A T I O N M
L B C R Y A F N U K P Q D C Z A R E C E J
V Y T J B B N H D S E W C G T H M D F F R
L J K I A A C W P I Y V N H D L C O E S A
Meetings between Associations & Farmaindustria
S B E R C J H Y U I M R A J H G V F R U Z
I K L J N T Y T R A I N I N G D C B A H D
O R G A N I Z A T I O N E X R G T I J N B
C V F R G H N J Z L E A D E R S H I P L K
O H K K N O W L E D G E S C X A W Q N U K
N H Y I K L P C D F F C A W E Q X Z L P H
Y J I U B F R E C O M M E N D A T I O N M
L B C R Y A F N U K P Q D C Z A R E C E J
V Y T J B B N H D S E W C G T H M D F F R
L J K I A A C W P I Y V N H D L C O E S A
Lisa SullivanIn Vivo Communications
& WentzMiller Global Services
How can venues & destinations strengthen their partnership with medical meetings
International Congress and Convention Association.
My coverage
International Congress and Convention Association.
Trends in CME/CPD
Accredited CME/CPD requirements are on the rise in emerging markets
India’s states are mandating CME and there is a push towards national structure
China now has mandatory CME/CPD and may start penalties for non-compliance
Indonesia instituted a sophisticated CPD programAsia Healthcare Meetings Forum calls for an
improved focus on CME/CPD accreditation US Grant based sponsorship of CME/CPD just
starting to venture into Australia/AsiaCommercial support spending is down for
CME/CPD as well as exhibits
International Congress and Convention Association.
Trends
More creativity needed from medical societies to maintain attendance with less industry support
Millennials emphasize online, social media to learn and interact with patients
CME/CPD meetings structure will force venues to be more flexible/workshops/interactive
International Congress and Convention Association.
Survey of healthcare managers Asia Healthcare Meetings Forum Oct 2014
How do you feel about the future of the healthcare sector meetings?
International Congress and Convention Association.
Survey of healthcare managers Asia Healthcare Meetings Forum Oct 2014
Do you think healthcare/lifescience sponsorship of HCP attendees to medical congresses is…? [Med society-Healthcare company-Agency]
International Congress and Convention Association.
Survey of healthcare managers Asia Healthcare Meetings Forum Oct 2014
To what extent will exhibit booths continue to be an important part of scientific exchange? [Med society-Healthcare company-Agency]
International Congress and Convention Association.
Should venue managers worry?
YesOver time, doctors will migrate to more personalized learning, fewer large meetings
Possible solutions
Flexible use of space/ smaller sessions, workshops
Incorporate technology to personalize learning onsite with social interaction
Don’t create roadblocks to providers using your space (e.g. inability to use external AV companies)
Help providers market more extensively especially accredited CME/CPD
Table DiscussionIdentify new ideas
What solutions can be implemented in your
organization
Record ideas/solutions on flip charts
Identify 1-2 key ideas from each table
And please share the talk time
Annalisa PonchiaEuropean Society for Organ
TransplantThe changing role of medical associations & societies
52nd ICCA Congress
International Congress and Convention Association.
Twitter: #ICCA13
“Where does it hurt?”Can international healthcare meetings evolve swiftly enough to meet the pressures to become more transparent, more educationally effective, and still remain financially viable?
Annalisa Ponchia BaccaraExecutive OfficerEuropean Society for Organ Transplantation
International Congress and Convention Association.
Twitter: #ICCA13
ESOT main agenda is delivering Education Medical Education cannot be delivered without the necessary financial supportPharma Industry has played a major role financing Medical Education, sometime conflicting with branded education platforms and meetings
Reduced sponsorship have forced our Organization to reshape the business model and to redefine formats and programs
Medical Societies have now the opportunity to bridge the gap that compliance necessities could create
The rationale
Jan SamynSeauton International
The changing role of medical associations & societies
Table DiscussionWhat are we waiting
for?
What can you do?
Record ideas/solutions on flip charts
Identify 1-2 key ideas from each table
And please share the talk time
Key Ideas
Changing role of medical
associations
Venues & destinations as partners
Working within
restrictions of compliance
Thanks to our speakers!• Christine Sainvil• Martin Jensen• Christoph Tessmar• Lisa Sullivan• Annalisa Ponchia• Jan Samyn
Healthcare Meetings Sector: Where does it Hurt this Year?
Thank you for attending!
55th ICCA Congress